New drug pricing: Will it be affordable?
“Affordable” is subjective
More appropriate measure: “Valuable”
- Increased disease targeting will outweigh costs of hospitalizations, work downtime costs, recurrence of disease, etc.
Inevitable that prices will continue to increase
- Focus on more complex diseases, using the latest technology
- Increasing R&D and manufacturing costs